Albutein Injection, Solution
NDC Package 68516-5215-2
Package Information
Albutein (albumin (human)) injection is hypersensitivity to albumin preparations or to any of the excipients.Severe anemia or cardiac failure with normal or increased intravascular volume. This formulation utilizes a injection, solution delivery system. Marketed by Grifols Usa, Llc, this product is identified by NDC 68516-5215 and is authorized under FDA application BLA102478.
Identification & Billing
- RxCUI: 1741290 - albumin human 20 % in 50 ML Injection
- RxCUI: 1741290 - 50 ML albumin human, USP 200 MG/ML Injection
- RxCUI: 1741290 - albumin human 10 GM per 50 ML Injection
- RxCUI: 1741290 - albumin human 20 % per 50 ML Injection
- RxCUI: 1741295 - albumin human 20 % in 100 ML Injection
Clinical Specifications
- Intravenous - Administration within or into a vein or veins.
- Intravenous - Administration within or into a vein or veins.
- Human Serum Albumin - [EPC] (Established Pharmacologic Class)
- Increased Intravascular Volume - [PE] (Physiologic Effect)
- Increased Oncotic Pressure - [PE] (Physiologic Effect)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Serum Albumin - [Chemical/Ingredient]
- Human Serum Albumin - [EPC] (Established Pharmacologic Class)
- Increased Intravascular Volume - [PE] (Physiologic Effect)
- Increased Oncotic Pressure - [PE] (Physiologic Effect)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Serum Albumin - [Chemical/Ingredient]
Regulatory & Marketing
Hierarchy Structure
- 68516 - Grifols Usa, Llc
- 68516-5215 - Albutein
- 68516-5215-2 - 1 VIAL in 1 CARTON / 100 mL in 1 VIAL (68516-5215-4)
- 68516-5215 - Albutein
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (68516-5215). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68516-5215-2 identifies a specific commercial package of 1 vial in 1 carton / 100 ml in 1 vial (68516-5215-4) of Albutein, a plasma derivative labeled by Grifols Usa, Llc. This injection, solution is formulated for intravenous use and contains albumin human as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Grifols Usa, Llc on March 01, 2022. The current certification is valid through December 31, 2026.
How is this Grifols Usa, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68516521502. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.